# Fortress Biotech, Inc.: Form 8-K, filed Feb 15, 2019

- Company: [Fortress Biotech, Inc.](/companies/fbio.md) (CIK 1429260)
- Form: 8-K
- Filed: 2019-02-15
- Accepted by EDGAR: Feb 15, 2019, 15:01 ET
- Period: 2019-02-11
- Accession: 0001144204-19-008647
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1429260/000114420419008647/tv513257_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1429260/000114420419008647/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1429260/000114420419008647/tv513257_8k.htm

Filed Feb 15, 2019.
Source: SEC EDGAR, the filing index for accession 0001144204-19-008647. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
